<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">347817</id>
  <title nil="true"/>
  <common-name>Dipropan-2-yl 3-(4-chlorobenzoyl)-7-pyridin-4-ylindolizine-1,2-dicarboxylate</common-name>
  <description>Dipropan-2-yl 3-(4-chlorobenzoyl)-7-pyridin-4-ylindolizine-1,2-dicarboxylate is a chemical compound with the formula C28H25ClN2O5. With an average molecular weight of 505.00 g/mol, Dipropan-2-yl 3-(4-chlorobenzoyl)-7-pyridin-4-ylindolizine-1,2-dicarboxylate is a heavy molecule.</description>
  <cas>853334-29-9</cas>
  <pubchem-id>45051506</pubchem-id>
  <chemical-formula>C28H25ClN2O5</chemical-formula>
  <weight>505</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-31T11:38:33Z</created-at>
  <updated-at type="dateTime">2026-08-31T11:38:33Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>CC(C)OC(=O)C1=C2C=C(C=CN2C(=C1C(=O)OC(C)C)C(=O)C3=CC=C(C=C3)Cl)C4=CC=NC=C4</moldb-smiles>
  <moldb-formula>C28H25ClN2O5</moldb-formula>
  <moldb-inchi>InChI=1S/C28H25ClN2O5/c1-16(2)35-27(33)23-22-15-20(18-9-12-30-13-10-18)11-14-31(22)25(24(23)28(34)36-17(3)4)26(32)19-5-7-21(29)8-6-19/h5-17H,1-4H3</moldb-inchi>
  <moldb-inchikey>AOKIQGYAABXNMT-UHFFFAOYSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">504.1451996</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>6.7</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM343710</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>Dipropan-2-yl 3-(4-chlorobenzoyl)-7-pyridin-4-ylindolizine-1,2-dicarboxylate</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Organic oxygen compounds</superklass>
  <klass>Organooxygen compounds</klass>
  <subklass>Carbonyl compounds</subklass>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0298154</sync-id>
  <structure-inchikey>AOKIQGYAABXNMT-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>40400000000400000400004000000000000040000000000000000080000000000000001000000000000000000000002100000000000000000000000000200000000000000080400000600000000000000020000000000100000000000000008000004000010080000000000400120000000000000900000000000000000000000000000040020000000400000080000040c00000000000800000000000000000000000000000040000000000084000000000020000000000000000000000000000000000000000001000000000000000000010004000000000000200000100000000000000000400002040000000000400000000000840200000000000000000</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAkAAAAJwAAAIABBgBgAAAAAQMGAGAAAAAD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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:46:23Z</structure-indexed-at>
</compound>
